Literature DB >> 3346778

Secondary carnitine deficiency in hyperammonemic attacks of ornithine transcarbamylase deficiency.

Y Ohtani1, K Ohyanagi, S Yamamoto, I Matsuda.   

Abstract

Carnitine status was evaluated in 12 patients with hyperammonemic attacks caused by a deficiency in ornithine transcarbamylase. We found decreased free carnitine and increased acylcarnitine levels in the serum, a decreased free carnitine content and an elevated acyl/free carnitine ratio in the liver, and increased excretion of free and acylcarnitine in the urine. Analyses of urinary acylcarnitine using the secondary ion mass spectrometry technique revealed increased amounts of acetylcarnitine and dicarboxylic acid derivatives. These data suggest that the patients had a secondary carnitine deficiency, possibly an aggravating factor in urea cycle dysfunction. After oral administration of L-carnitine (50 to 100 mg/kg/d) in two patients, hyperammonemic episodes were less frequent. Blood ammonia levels decreased significantly, accompanied by an increase in serum free carnitine levels.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3346778     DOI: 10.1016/s0022-3476(88)80321-4

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  13 in total

Review 1.  L-Carnitine.

Authors:  J H Walter
Journal:  Arch Dis Child       Date:  1996-06       Impact factor: 3.791

2.  Three cases of intravenous sodium benzoate and sodium phenylacetate toxicity occurring in the treatment of acute hyperammonaemia.

Authors:  V Praphanphoj; S A Boyadjiev; L J Waber; S W Brusilow; M T Geraghty
Journal:  J Inherit Metab Dis       Date:  2000-03       Impact factor: 4.982

3.  Controlled diet in phenylketonuria may cause serum carnitine deficiency.

Authors:  M A Vilaseca; P Briones; I Ferrer; J Campistol; A Riverola; P Castillo; F Ramon
Journal:  J Inherit Metab Dis       Date:  1993       Impact factor: 4.982

Review 4.  Alternative pathway therapy for urea cycle disorders.

Authors:  F Feillet; J V Leonard
Journal:  J Inherit Metab Dis       Date:  1998       Impact factor: 4.982

5.  Acute hemodialysis for hyperammonemia in small neonates.

Authors:  Deepak K Rajpoot; John J Gargus
Journal:  Pediatr Nephrol       Date:  2004-03-02       Impact factor: 3.714

6.  Neonatal citrullinaemia with satisfactory mental development.

Authors:  P Sanjurjo; J Rodríguez-Soriano; A Vallo; A Arranz; V Rubio
Journal:  Eur J Pediatr       Date:  1991-08       Impact factor: 3.183

7.  A case of carbamylphosphate synthetase-I deficiency associated with secondary carnitine deficiency--L-carnitine treatment of CPS-I deficiency.

Authors:  T Mori; A Tsuchiyama; K Nagai; M Nagao; K Oyanagi; S Tsugawa
Journal:  Eur J Pediatr       Date:  1990-01       Impact factor: 3.183

Review 8.  Emergency management of inherited metabolic diseases.

Authors:  V Prietsch; M Lindner; J Zschocke; W L Nyhan; G F Hoffmann
Journal:  J Inherit Metab Dis       Date:  2002-11       Impact factor: 4.982

Review 9.  Suggested guidelines for the diagnosis and management of urea cycle disorders.

Authors:  Johannes Häberle; Nathalie Boddaert; Alberto Burlina; Anupam Chakrapani; Marjorie Dixon; Martina Huemer; Daniela Karall; Diego Martinelli; Pablo Sanjurjo Crespo; René Santer; Aude Servais; Vassili Valayannopoulos; Martin Lindner; Vicente Rubio; Carlo Dionisi-Vici
Journal:  Orphanet J Rare Dis       Date:  2012-05-29       Impact factor: 4.123

10.  Hyperammonemia: What Urea-lly Need to Know: Case Report of Severe Noncirrhotic Hyperammonemic Encephalopathy and Review of the Literature.

Authors:  Ruby Upadhyay; Thomas P Bleck; Katharina M Busl
Journal:  Case Rep Med       Date:  2016-09-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.